ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Clinical Lymphoma Myeloma & Leukemia(2018)
Key words
chronic myeloid leukemia,treatment-free remission,nilotinib,deep molecular response,second-generation tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined